US Patent Issued to Colorado State University Research Foundation, Dynavax Technologies on April 21 for "Production of vaccines comprising inactivated SARS-CoV-2 viral particles" (Colorado Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,442, issued on April 21, was assigned to Colorado State University Research Foundation (Fort Collins, Colo.) and Dynavax Technologies Corp. (Emeryville, Calif.).

"Production of vaccines comprising inactivated SARS-CoV-2 viral particles" was invented by Raymond P. Goodrich (Fort Collins, Colo.) and Richard Bowen (Fort Collins, Colo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods for inactivating a viral particle, the methods comprising contacting the viral particle with UV light in the presence of riboflavin. In some embodiments, the viral particle is a SARS-CoV-2 particle. Vaccine compositions comprising inactivated vira...